Research article · 6 Oct 2026
Conference abstractPublished 14 Jul 2014
Development and characterization of a novel topical polymeric nanomicellar formulation (size 25- 30 nm) for intermediate and posterior uveitis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: To develop Dexamethasone (DEX) loaded polymeric nanomicelles in size range of 25-30nm using experimental design. Methods: A low molecular weight diblock co-polymers (PCL2500-mPEG2000) was synthesized by ring opening polymerization using mPEG as initiator and stannous octoate as catalyst. Polymerwas characterized by H1 NMR, IR spectroscopy, gel permeation chromatography, critical micelle concentration (CMC) and cytotoxicity studies in corneal, conjunctival and retinal cell-lines. DEX-loaded nanomicelles were prepared by film hydration method. In order to understand the drug-polymer interactions influencing drug solubilization in micelle core, a 2factors-3 level response surface methodology was generated using SAS9.02 (exploratory model).The independent factors were polymer amount (X1) and DEX amount(X2). Solubility of DEX in micelle solution was taken as response variable (Y). Micelle preparation method was modified based on the results obtained from exploratory model. The formulation was optimized by another response surface design (optimization model to achieve DEX solubility of 1mg/mL). The optimized formulation was characterized for solubility of DEX, micelle size and PDI & TEM analysis. The formulation was also subjected to in vitro transport across conjunctival cellline and ex vivo transport across excised rabbit?s clera. Results: The Mw, Mn and PDI for newly synthesized polymer were 4586 Da, 3155 Da and 1.45, respectively. The CMC was determined by pyrene method and was found to be 12.3µg/mL. The information on DEX-polymer interactions obtained from exploratory model was utilized to modify the micelle preparation method to obtain optimized nanomicellar formulation of DEX (1 mg/mL). The optimized nanomicelle formulation exhibited mean size in range of 25-30 nm with unimodel size distribution and low polydispersity. The nanomicelles increased DEX permeability by 2 fold across conjunctival cell line and by ~2.5 fold across the excised rabbit?s clear as compared to DEX suspension. Conclusion: The design of experiment was successfully utilized for understanding the effects of drug-polymer interaction on DEX solubility. The exploratory model further helped to improve DEX solubility in micelle core. Higher permeability of DEX was observed across both conjunctival cell line and excised rabbits clera with nanomicellar formulation.
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Experimental Ophthalmology.
Short communication · 30 Aug 2026
Vision Science in the Modern Era: Integrating Neuroscience, Genetics, and Technology
Commentary · 3 Aug 2026
Emerging Frontiers in Experimental Ophthalmology: Innovations and Translational Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Ravi Vaishya”
